Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001644956-25-000038
Filing Date
2025-07-30
Accepted
2025-07-30 13:01:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4909
  Complete submission text file 0001644956-25-000038.txt   6550
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Subject) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-40503 | Film No.: 251165682
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 150 NORTH RIVERSIDE PLAZA CHICAGO IL 60606
Business Address 150 NORTH RIVERSIDE PLAZA CHICAGO IL 60606 312-236-1600
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by) CIK: 0001644956 (see all company filings)

EIN.: 472614791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A